ArticleJournal of neurovirology2012

Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.

Simone Giannecchini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.